Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-03-16

Clinical Trial Update: Early Fluid Resuscitation With Balanced HES 130/0.4 [6%] in Severe Burn Injury [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating early fluid resuscitation with balanced hydroxyethyl starch (HES 130/0.4, 6%) for severe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxyethyl starch 130/0.4 (6%) balanced solution (hydroxyethyl starch)

Snippet

Sponsor: University of Zurich | Conditions: Burns | Phase 4 | Status: UNKNOWN